Publications

October 2024
Case

Allurion: Competing in the Age of GLP-1

By: Satish Tadikonda, Rajiv Lal, David Lane and Sarah Sasso

Shantanu Gaur had built Allurion into a formidable business internationally, providing obesity patients with a less invasive option long before GLP-1 drugs became the latest craze. Selling Allurion's medical device across 60+ countries, he awaited FDA approval to bring... View Details

Keywords: Corporate Entrepreneurship; Health Care and Treatment; Global Strategy; Competitive Strategy; Market Entry and Exit; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States; United Kingdom; France; India; Brazil; Middle East

September 2022
Technical Note

Addressing Social Determinants of Health in the American Landscape

By: Susanna Gallani and Jacob Riegler

Social determinants of health (SDOH) have gained significant attention in recent years. A growing body of research shows that a person’s health is influenced by a large number of non-genetic factors, most of which operate outside the realm of health care and are... View Details

Keywords: Socioeconomic Determinants Of Health; Social Determinants Of Health; Population Health; Health; Health Care and Treatment; Social Issues; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States

July 2008 (Revised August 2008)
Case

In-Vitro Fertilization: Outcomes Measurement

By: Michael E. Porter, Saquib Rahim and Benjamin Chung-Shi Tsai

As of 2007, there were very few examples of widespread measurement and reporting of health outcomes, a critical quality measure. In-vitro fertilization clinics have been required to report their patient's health outcomes since 1995. The protagonist of the case, Dr.... View Details

Keywords: Health Care and Treatment; Medical Specialties; Measurement and Metrics; Operations; Outcome or Result; Health Industry; Cleveland

Summer 2023
Article

Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?

By: Eric Barrette, Leemore S. Dafny and Karen Shen

Even among commercially insured individuals, opioid use disorder is undertreated in the United States: nearly half receive no treatment within six months of a new diagnosis. Using a difference-in-differences specification exploiting the extension of insurance parity... View Details

Keywords: Opioid Treatment; Medication-assisted Treatment; Substance Use Disorder; Private Insurance; Insurance; Health Care and Treatment

Find at Harvard

Web

MS/MBA Biotechnology: Life Sciences | MBA

MS/MBA Biotechnology: Life Sciences Joint degree with the Graduate School of Arts and Sciences. Students are affiliated with Harvard Medical School through the Harvard Department of Stem Cell and Regenerative Biology. Play A joint degree... View Details

30 Mar 2020
News

Why Is the U.S. Behind on Coronavirus Testing?

Richard G. Hamermesh

Richard Hamermesh was the MBA Class of 1961 Professor of Management Practice at the Harvard Business School. While at HBS Richard served as co-chair of the HBS Healthcare... View Details

Keywords: health care

Web

Faculty & Advisors | MBA

Technology Chris leads MPM Capital’s public market investing as portfolio manager for BioImpact Equities (formerly known as Burrage Capital) and the Oncology Impact Funds. Previously, Chris was a health care analyst at Fidelity... View Details

April 2012 (Revised February 2013)
Case

Learning About Reducing Hospital Mortality at Kaiser Permanente

By: Anita Tucker

In 2011, Kaiser Permanente Northern California (KPNC) region's efforts to reduce mortality in their 21 hospitals is showing promise. They developed and launched a region-wide initiative to improve the treatment of sepsis, a serious and often deadly medical condition.... View Details

Keywords: Change Management; Health Care and Treatment; Performance Improvement; Health Industry; California

March 2022 (Revised August 2022)
Case

Proximie: Using XR Technology to Create Borderless Operating Rooms

By: Ariel D. Stern and Alpana Thapar

In mid-January 2022, Nadine Hachach-Haram, founder and CEO of Proximie, was thinking about the company’s growth plans. Launched in 2016, Proximie was a platform that enabled clinicians, proctors, and medical device company personnel to be virtually present in operating... View Details

Keywords: Growth and Development Strategy; Technological Innovation; Partners and Partnerships; Strategic Planning; Health Care and Treatment; Analytics and Data Science; Digital Platforms; Health Industry; Lebanon; United Kingdom; United States

January 2008
Article

How to Change the World

By: Howard H. Stevenson

Alan Wilson has a decision to make. The CEO of his company, Grepter, wants him to relocate to Zurich, where he can gain valuable experience for a rise to the top. Karl, his best friend, hopes to lure him to a hedge fund that promises big money fast. Shiori, an enticing... View Details

Keywords: Decision Choices and Conditions; Values and Beliefs; Compensation and Benefits; Personal Development and Career; Power and Influence

Find at Harvard

March 2000
Case

Heartport, Inc.

By: Gary P. Pisano and Shoshana Dobrow

Heartport, an entrepreneurial medical device maker, has introduced several innovative systems for conducting less-invasive cardiac surgery. Despite initially high expectations, the company has struggled to get its technology adopted by cardiac surgeons. The company's... View Details

Keywords: History; Product Positioning; Knowledge Acquisition; Corporate Entrepreneurship; Technology Adoption; Health Care and Treatment

March 2016
Case

Residency Select or J3Personica?

By: William Kerr and Kathryn S. Roloff

Residency Select, LLC provides psychometric assessments for matching medical students to residency programs. After a series of successful pilots, founder Alan Friedman is considering whether to continue developing his offerings in this area, or whether to expand into... View Details

Keywords: Marketplace Matching; Expansion; Higher Education; Entrepreneurship; Health Care and Treatment; Growth and Development Strategy; Service Industry

August 2023
Case

Augmenix: Space to Think Differently

By: Satish Tadikonda and Sidhant Jena

Amar Sawhney, a serial medtech entrepreneur, had founded Augmenix to develop and commercialize a hydrogel-based medical device called SpaceOAR as an adjunctive technology to core radiation therapy. This technology was used to protect organs at risk (OAR) during... View Details

Keywords: Entrepreneurship; Health Care and Treatment; Technology Adoption; Innovation Strategy; Technological Innovation; Product Development; Commercialization; Medical Devices and Supplies Industry

26 Nov 2013
First Look

First Look: November 26

identifying the types of GPs that drive the identified correlation between GPs and reduced shareholder value. Publisher's link: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1718488 August 2013 American Journal of Managed Care... View Details

Keywords: Sean Silverthorne

2007
Book

Perspectives on Risk and Regulation: The FDA at 100

By: Arthur A. Daemmrich and Joanna Radin

Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details

Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation

Find at Harvard

Read Now

Web

Tuition & Financial Support - Doctoral

payments, providing financial relief during the academic year. In addition, our students are eligible for the Graduate School of Arts and Sciences Parental Accommodations and Financial Support program . Care Fellowship : Unforeseen View Details

May 2014 (Revised January 2015)
Case

Vaxess Technologies, Inc.

By: John A. Quelch and Margaret L. Rodriguez

In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details

Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry